Sophos Tops 2023 Gartner Magic Quadrant for Endpoint Protection.
Sophos, a global leader in innovating and delivering cybersecurity as a service, announced that it is positioned as a Leader in the 2023 Gartner® Magic Quadrant™ for Endpoint Protection Platforms [EPP], marking the 14th consecutive time the company has been a Leader in the report.
Sophos Intercept X defends more than 300,000 organizations from ransomware, exploited software vulnerabilities and other modern cyberattacks, and leverages deep learning artificial intelligence [AI] to enhance protections. Intercept X includes the industry-first Adaptive Attack Protection, which automatically disrupts in-progress attacks and dynamically puts “shields up” to give defenders valuable additional time to respond to an intrusion. The Account Health Check capability also identifies security posture drift and misconfigurations, and provides the ability to remediate these issues with one click.
“We believe Gartner recognized Sophos again, due to our market-leading and flagship EPP solution, a Leader in this Magic Quadrant because we are consistently innovating our protection-first technologies to defeat current and changing cyberattacks,” said Raja Patel, chief product officer at Sophos. “Security vendors cannot stay static. There’s too much at stake. Adversaries will always look for the easiest and newest ways to avoid detection or take advantage of misconfigurations and other security gaps to reach their endgame. That’s why we always prioritize adaptive and preventative EPP defenses for our customers.”
Sophos Intercept X with Extended Detection and Response [XDR] integrates telemetry sources from numerous technology and security providers, including Microsoft, Amazon Web Services [AWS], Google, CrowdStrike, Palo Alto Networks, Cisco Systems, Fortinet, Check Point, Duo, Proofpoint, Darktrace, and many others, through the Sophos Marketplace. Enhanced security operations and analyst workflow and case management features collate redundant alerts, offer complete visibility from a single console and reduce workloads with automated responses.
Already this year, Sophos was named a Customers’ Choice in the Gartner® Peer Insights™ Voice of the Customer for Endpoint Protection Platforms [EPP] report. Sophos was the only vendor recognized as a Customer’s Choice across EPP, managed detection and response [MDR], network firewalls, and mobile threat defense. Like Intercept X, Sophos MDR is recognized and is the most reviewed MDR solution on Gartner Peer Insights and G2. As the most widely used MDR offering with more than 19,000 customers, Sophos MDR is the only MDR service that can be delivered across end users’ existing third-party security deployments as well as Sophos offerings.
Managed in the cloud-native Sophos Central platform, Sophos’ portfolio solutions are part of the Sophos Adaptive Cybersecurity Ecosystem, where security data is collected, correlated and enriched with additional context to enable automatic and synchronized responses to active threats. This platform is further optimized by Sophos X-Ops’ real-time and historical threat intelligence and expertise.
Gartner Peer Insights content consists of the opinions of individual end users based on their own experiences with the vendors listed on the platform, should not be construed as statements of fact, nor do they represent the views of Gartner or its affiliates. Gartner does not endorse any vendor, product or service depicted in this content nor makes any warranties, expressed or implied, with respect to this content, about its accuracy or completeness, including any warranties of merchantability or fitness for a particular purpose.
Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
About The Author
